Evaluation of intact proinsulin levels reveals significant decreases with tirzepatide at 5, 10, and 15 mg doses, indicating potential positive changes in insulin processing.Furthermore, tirzepatide therapy dramatically lowers glucose-adjusted glucagon levels, emphasizing improvements in glucose regulation, beta-cell activity, insulin processing, and reduced glucagon levels [74]
Abstract Purpose of Review Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including Semaglutide, are promising therapeutic options for glycemic control and weight management in type 2 diabetes (T2DM) and post-transplant diabetes mellitus (PTDM)
Retatrutide is a synthetic drug that simultaneously acts on multiple receptors
Jastreboff AM, le Roux CW, Stefanski A, et al
doi: 10.1021/acs.chemrev.0c00761 81 XuKLiKHeYMaoYLiXZhangLet al